Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23116
Title: | CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980 |
Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
Keywords: | Adult,Aged,Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use,Brain Neoplasms/*drug therapy,Carbamates/administration & dosage/adverse effects/*therapeutic use,Disease-Free Survival,Female,Glioma/*drug therapy,Humans,Infusions, Intravenous,Male,Maximum Tolerated Dose,Middle Aged,Neoplasm Recurrence, Local/*drug therapy,Pyrazines/administration & dosage/adverse effects/*therapeutic use,Pyridines/administration & dosage/adverse effects/*therapeutic use,Survival Rate,Thrombocytopenia/chemically induced,Treatment Outcome |
URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/23116 |
ISSN: | 0735-7907 |
Link: | http://www.ncbi.nlm.nih.gov/pubmed/12449727 |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License